Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
A 2025 pilot human IV study at 1020mg reported a favorable safety profile with no serious adverse events
Delivery times assume that payment is made before 3PM
Jelovac, N et al
Clinical observations report that patients using BPC-157 experience significant improvements in mobility and pain reduction, with some reporting relief lasting six months or longer from a single injection
Severe adverse events have not been a pattern in community usage, but human safety data is limited to a few pilot studies
Combined subcutaneous: KPV 250 mcg subQ daily and BPC-157 250 mcg subQ daily for 6 to 8 weeks
US$ 26.07
US$ 21.09
US$ 27.75
US$ 20.42
US$ 25.95
US$ 24.18
US$ 29.82
